These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 32118794)

  • 21. Hepatitis B reactivation after kidney transplantation in hepatitis B surface antigen-negative, core antibody-positive recipients.
    Kim J; Chung SJ; Sinn DH; Lee KW; Park JB; Huh W; Lee JE; Jang HR; Kang W; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
    J Viral Hepat; 2020 Jul; 27(7):739-746. PubMed ID: 32057171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kidney transplantation from anti-HBc+ donors: results from a retrospective Italian study.
    De Feo TM; Grossi P; Poli F; Mozzi F; Messa P; Minetti E; Sandrini S; Boschiero L; Rigotti P; Maresca C; Rolla D; Chiaramonte S; Gotti E; Caldara R; Briano G; Scalamogna M
    Transplantation; 2006 Jan; 81(1):76-80. PubMed ID: 16421480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis B reactivation in occult viral carriers undergoing hematopoietic stem cell transplantation: A prospective study.
    Seto WK; Chan TS; Hwang YY; Wong DK; Fung J; Liu KS; Gill H; Lam YF; Lau EHY; Cheung KS; Lie AKW; Lai CL; Kwong YL; Yuen MF
    Hepatology; 2017 May; 65(5):1451-1461. PubMed ID: 28027590
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Persistent risk of HBV reactivation despite extensive lamivudine prophylaxis in haematopoietic stem cell transplant recipients who are anti-HBc-positive or HBV-negative recipients with an anti-HBc-positive donor.
    Cerva C; Colagrossi L; Maffongelli G; Salpini R; Di Carlo D; Malagnino V; Battisti A; Ricciardi A; Pollicita M; Bianchi A; Picardi A; Cudillo L; Cerretti R; De Angelis G; Cantonetti M; Andreoni M; Perno CF; Arcese W; Svicher V; Sarmati L
    Clin Microbiol Infect; 2016 Nov; 22(11):946.e1-946.e8. PubMed ID: 27475741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Utilization of hepatitis B core antibody positive grafts in living donor liver transplantation.
    Udayakumar VP; Surendran S; Padma UD
    Indian J Gastroenterol; 2018 Jan; 37(1):39-43. PubMed ID: 29450703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The difficulties of managing severe hepatitis B virus reactivation.
    Roche B; Samuel D
    Liver Int; 2011 Jan; 31 Suppl 1():104-10. PubMed ID: 21205146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of prophylactic antiviral therapy and outcomes in HBsAg-negative, anti-HBc-positive patients receiving chemotherapy: a real-life experience.
    Papadopoulos N; Deutsch M; Manolakopoulos S; Bitsi C; Michalakeas H; Poulakidas H; Tsironi E; Giannouli S; Papatheodoridis GV; Koskinas J; Pectasides D
    Eur J Gastroenterol Hepatol; 2017 Jan; 29(1):56-60. PubMed ID: 27669175
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    Bedi HK; Trasolini R; Lowe CF; Hussaini T; Bigham M; Ritchie G; Yoshida EM
    Hepatol Forum; 2021 Sep; 2(3):117-119. PubMed ID: 35784901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transmission of viral hepatitis by kidney transplantation: donor evaluation and transplant policies (Part 1: hepatitis B virus).
    Natov SN; Pereira BJ
    Transpl Infect Dis; 2002 Sep; 4(3):117-23. PubMed ID: 12421455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis B Virus Reactivation in Non-Liver Solid Organ Transplantation: Incidence and Risk Analysis.
    Chiu CY; Brumble LM; Vikram HR; Watt KD; Beam E
    Clin Transplant; 2024 Jul; 38(7):e15389. PubMed ID: 38952185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of liver grafts from donors positive for antihepatitis B-core antibody (anti-HBc) in the era of prophylaxis with hepatitis-B immunoglobulin and lamivudine.
    Nery JR; Nery-Avila C; Reddy KR; Cirocco R; Weppler D; Levi DM; Nishida S; Madariaga J; Kato T; Ruiz P; Schiff E; Tzakis AG
    Transplantation; 2003 Apr; 75(8):1179-86. PubMed ID: 12717200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis B and C serologic profiles of Canadian organ donors and recipients: retrospective 10-year review at a single center.
    Burton CE; Doucette KE; Mabilangan CA; Plitt SS; Lee BE; Preiksaitis JK
    Transpl Infect Dis; 2016 Aug; 18(4):520-8. PubMed ID: 27226204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention of de novo hepatitis B virus infection in living donor liver transplantation using hepatitis B core antibody positive donors.
    Chen YS; Wang CC; de Villa VH; Wang SH; Cheng YF; Huang TL; Jawan B; Chiu KW; Chen CL
    Clin Transplant; 2002 Dec; 16(6):405-9. PubMed ID: 12437618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population.
    Prieto M; Gómez MD; Berenguer M; Córdoba J; Rayón JM; Pastor M; García-Herola A; Nicolás D; Carrasco D; Orbis JF; Mir J; Berenguer J
    Liver Transpl; 2001 Jan; 7(1):51-8. PubMed ID: 11150423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Escape hepatitis B virus mutations in recipients of antibody to hepatitis B core antigen-positive liver grafts receiving hepatitis B immunoglobulins.
    Roche B; Roque-Afonso AM; Sebagh M; Delvart V; Duclos-Vallee JC; Castaing D; Samuel D
    Liver Transpl; 2010 Jul; 16(7):885-94. PubMed ID: 20583085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A multicenter evaluation of hepatitis B reactivation with and without antiviral prophylaxis after kidney transplantation.
    Shaikh SA; Kahn J; Aksentijevic A; Kawewat-Ho P; Bixby A; Rendulic T; Park JM
    Transpl Infect Dis; 2022 Feb; 24(1):e13751. PubMed ID: 34725887
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical impact and efficacy of lamivudine therapy in de novo hepatitis B infection after liver transplantation.
    Castells L; Vargas V; Rodríguez F; Allende H; Buti M; Sánchez-Avila JF; Jardí R; Margarit C; Pumarola T; Esteban R; Guardia J
    Liver Transpl; 2002 Oct; 8(10):892-900. PubMed ID: 12360430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and chemotherapy-induced reactivation of occult hepatitis B virus among hepatitis B surface antigen negative patients with diffuse large B-cell lymphoma: significance of hepatitis B core antibodies screening.
    Elbedewy TA; Elashtokhy HE; Rabee ES; Kheder GE
    J Egypt Natl Canc Inst; 2015 Mar; 27(1):11-8. PubMed ID: 25716703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Self-limited HBV infection of the recipient does not reactivate after liver transplantation: Observations from a 30-year liver transplant program.
    Ossami Saidy RR; Demir M; Nibbe P; Dobrindt EM; Oellinger R; Schoening W; Pratschke J; Eurich D
    Transpl Infect Dis; 2021 Feb; 23(1):e13436. PubMed ID: 32748492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Solid-organ transplantation in HBsAg-negative patients with antibodies to HBV core antigen: low risk of HBV reactivation.
    Knöll A; Pietrzyk M; Loss M; Goetz WA; Jilg W
    Transplantation; 2005 Jun; 79(11):1631-3. PubMed ID: 15940056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.